Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 3Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Xerostomia 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Radiation Injuries 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Hydatidiform Mole 1Hepatoblastoma 1Head and Neck Neoplasms 1Gestational Trophoblastic Disease 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Radiotherapy 8Cisplatin 3Carboplatin 3sargramostim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Donepezil 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vortioxetine 1Vitamin E 1Standard of Care 1Sodium Chloride 1Salts 1Radiotherapy, Conformal 1Radiosurgery 1Oxygen 1Oxaliplatin 1Neck Dissection 1Mometasone Furoate 1Meditation 1Hyperbaric Oxygenation 1Glutamine 1G(M1) Ganglioside 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiation Injuries × Amifostine × Clear all
NCT00003313 2014-11-21

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
243 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡